Latest News and Press Releases
Want to stay updated on the latest news?
-
Idorsia thanks Alberto Gimona – most recently Head of Global Clinical Development and Medical Affairs – and wishes him all the best for a well-deserved retirementAmer Joseph joins Idorsia as EVP,...
-
Austin, TX, USA, April 09, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Centrifugal High-Speed Separators Market Size, Trends and Insights By Type...
-
GLPro claims evaluated: GLP-1 blood sugar formula, bariatric gelatin trick recipe, Berberine HCL research, pricing, and 60-day guarantee reviewed.
-
IRVINE, Kalifornie, April 09, 2026 (GLOBE NEWSWIRE) -- iHerb, jeden z největších světových online prodejců zaměřených na zdraví a wellness, dnes oznámil uzavření exkluzivního mezinárodního...
-
IRVINE, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- iHerb, salah satu peruncit dalam talian terbesar di dunia yang mengkhusus kepada kesihatan dan kesejahteraan, hari ini mengumumkan kerjasama...
-
カリフォルニア州アーバイン発, April 09, 2026 (GLOBE NEWSWIRE) -- 健康・ウェルネス分野を専門とする世界最大級のオンライン小売業者であるアイハーブ (iHerb) は本日、カイリー・ジェンナー (Kylie Jenner) が設立したk2oとの独占的国際提携を発表した。...
-
IRVINE, California, April 09, 2026 (GLOBE NEWSWIRE) -- iHerb, salah satu peritel online terbesar di dunia dengan spesialisasi di bidang kesehatan dan kebugaran, hari ini mengumumkan kemitraan...
-
IRVINE, Kalifornien, April 09, 2026 (GLOBE NEWSWIRE) -- iHerb, einer der weltweit größten Online-Händler mit Schwerpunkt auf Gesundheit und Wellness gab heute eine exklusive internationale...
-
SlimCrystal crystal water bottle claims evaluated: odd water secret weight loss positioning, crystal healing context, pricing, and refund details
-
The Soleno complaint alleges that Soleno Phase 3 clinical trial program for DCCR had downplayed, misrepresented, and/or concealed safety concerns.
-
Found Health's GLP-1 program, insurance check, Wegovy, Zepbound, Ozempic access, compounded options, and 2026 pricing structure — evaluated.
-
Investors who lost money in QURE after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
-
Investors who lost money in IBRX after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
-
Investors who lost money in CORT after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
-
• Plan to resume enrollment in clinical study of lorigerlimab in gynecologic cancers • On track to provide mid-2026 program update ROCKVILLE, MD, April 08, 2026 (GLOBE NEWSWIRE) -- MacroGenics,...
-
AVITA Medical Secures 10-Year BARDA Agreement Worth Up to $25.5M to Bolster U.S. Burn Emergency Preparedness
-
SAN DIEGO, April 08, 2026 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that it will report first quarter 2026 financial results on Thursday, May 7, 2026 after...
-
SAN JOSE, Calif., April 08, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first of-its-kind technology to improve clinical outcomes in...
-
TitanFlow prostate supplement claims evaluated: Zenith Labs ingredient dosages, urethra support research, and urinary flow details for men 40+
-
BladderShield claims evaluated: bladder leak trick, urobiome research, ingredient findings for men's bladder health and urinary urgency reviewed.
-
Neura Supplement claims evaluated: 2026 report on the red goji berry recipe memory trick, cognitive shield ingredients, and brain fog research
-
PhenQ weight loss claims evaluated: 2026 update on α-Lacys Reset® dosages, thermogenic formula research, and label verification for buyers.
-
New York City, NY, April 08, 2026 (GLOBE NEWSWIRE) -- Introduction – Why Gelatide & the Gelatin Trick Recipe Are Gaining Attention in 2026 In 2026, the growing interest in simplified wellness...
-
New York, USA, April 08, 2026 (GLOBE NEWSWIRE) -- Interstitial Lung Disease Market to Witness Accelerated Growth at a CAGR of 8.7% During the Forecast Period (2026–2036) Due to the Launch of...
-
BROSSARD, Québec, 08 avr. 2026 (GLOBE NEWSWIRE) -- Diagnos inc. (« DIAGNOS » ou la « Société ») (Bourse de croissance TSX : ADK, OTCQB : DGNOF, FWB : 4D4A), une entreprise dédiée à la détection...
-
BROSSARD, Quebec, April 08, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of...
-
LOS ANGELES, April 08, 2026 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
-
HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with the Schall Law Firm
-
8. april 2026 Meddelelse nr. 7 BioPorto frasælger antistofforretning til Janel Life Sciences, LLC KØBENHAVN, DANMARK og BOSTON, MA, USA, 8. april, 2026 – BioPorto A/S ("BioPorto" eller "Selskabet")...
-
April 8, 2026 Company Announcement No. 7 BioPorto Successfully Completes Divestment of its Antibody Business to Janel Life Sciences, LLC COPENHAGEN, DENMARK and BOSTON, MA, USA, April 8, 2026 –...
-
China National Intellectual Property Administration has granted a patent covering potency assay methods for assessing human mesenchymal stem cells (MSCs).
-
VANCOUVER, British Columbia, April 08, 2026 (GLOBE NEWSWIRE) -- USANewsGroup.com News Commentary — Biotechs that went public in Q1 2026 raised a median of $287.5 million each; and nearly every one...
-
Mesoblast outlines commercial strategy to double net revenues as Ryoncil® approaches US$100M net revenue milestone since launch last year Showcases transformative blockbuster products for...
-
미국 캘리포니아주 어바인, April 08, 2026 (GLOBE NEWSWIRE) -- 건강 및 웰니스 제품을 전문으로 하는 세계 최대 온라인 유통업체 중 하나인 iHerb가 카일리 제너 (Kylie Jenner)가 설립한 k2o와의 독점 글로벌 파트너십을 발표했다. 이번 협력을 통해 iHerb는 k2o의 드링크 믹스를 전 세계 고객에게 곧 선보일...
-
Strong participation in recent $33 million common stock offering highlights investor confidence in late-stage clinical momentum and commercial potential Statistical assessments point to high...
-
Ritedose partners with Tenpoint Therapeutics to manufacture YUVEZZI™, the first FDA-approved dual-action eye drop for presbyopia.
-
Patent Expands Protection for the Company’s RenovoCath Device, the Novel Dual-Occlusion Catheter-Based System RenovoRx Currently Holds a Strong and Growing Global Intellectual Property Portfolio...
-
- Unprecedented improvements in arm span observed with TransCon CNP and TransCon hGH combination therapy, a measure highly meaningful to the achondroplasia community - Enhanced improvements in spinal...
-
Freiburg, Germany, April 08, 2026 (GLOBE NEWSWIRE) -- CorTec GmbH, a pioneer in fully implantable brain-computer interfaces (BCI), today announced that the U.S. Food and Drug Administration (FDA)...
-
– Educational campaign to raise awareness of recurrent pericarditis and to empower patients to discuss ARCALYST with their healthcare provider – – Media accompanying this announcement is available by...
-
Oak Ridge, TN, April 08, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, continues its strategic expansion with the launch of a...
-
DUBLIN and BRIDGEWATER, N.J., April 08, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) (“Amarin”), a company committed to advancing the science of cardiovascular disease (CVD)...
-
Preclinical milestone for selection and approval of first compound for lead optimization has been achievedFurther development validates the potential intended mechanistic effect of CUE-501 for T...
-
FORT MILL, S.C., April 08, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK) (“VTAK” or the “Company”) today announced that it will be attending the annual European Heart...
-
HOUSTON, April 08, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced...
-
– Encore data to be presented demonstrating that cebranopadol displays significant and sustained pain reduction with a distinguished safety profile following abdominoplasty and bunionectomy – –...
-
PMGC Holdings Inc. [NASDAQ: ELAB] PMGC Holdings Fully Utilizes All Available in $20M Equity Financing Facility, Strengthens Cash Position and Advances Mult
-
WELLESLEY HILLS, Mass., April 08, 2026 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for immune-mediated diseases, today...
-
SAN FRANCISCO, April 08, 2026 (GLOBE NEWSWIRE) -- Immusoft of CA, a clinical-stage biotechnology company pioneering engineered B cell therapies, today announced that it will present an invited...
-
NEW YORK, April 08, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today...